Eli Lilly and Company

(redirected from Eli Lilly and Co.)

Eli Lilly and Company

A major pharmaceutical company in the United States. It manufactures drugs for diabetes, cancer and other diseases. It was established in 1876 and is based in Indianapolis.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved
References in periodicals archive ?
INDIANAPOLIS -- Eli Lilly and Co. announced it plans to invest $72 million in an insulin manufacturing project at one of its facilities here.
Eli Lilly and Co., 3AN-06-05630 CI, Alaska Superior Court, Anchorage District.
Eli Lilly and Co. got plenty of attention yesterday when it announced the release of its new pen, the HumaPen Memoir, which it says is the first to keep detailed recordings of insulin injections.
Eli Lilly and Co., Indianapolis, Ind., CEO and Chairman Sidney Taurel recently made the case for a Japan-U.S.
Prozac, or fluoxetine, was developed by Eli Lilly and Co. and is now widely available in generic versions.
Bayer HealthCare of Leverkusen, Germany, calls the one it developed BAY 59-7939, and developer Eli Lilly and Co. of Indianapolis calls the other LY517717.
Officials with the Japan unit of Indiana-based Eli Lilly and Co. said earlier they made the decision following reports this year that 21 diabetics overseas were hospitalized after their blood sugar levels shot up in the wake of their use of the syringes.
Walton counseled on strategic marketing and promotional campaigns for clients such as Eli Lilly and Co., DuPont, Dow AgroSciences and Caterpillar.
The Food and Drug Administration has granted Eli Lilly and Co. Priority Review designation for its New Drug Application (NDA) for Verzenio (abemaciclib), a cyclin-dependent kinase (CDK) 4 & 6 inhibitor, as an initial treatment for advanced breast cancer.
Eli Lilly and Co., Indianapolis, Ind., has now partnered with the Harvard Medical School, Cambridge, Mass., to establish a brand new research program aimed at combating multi-drug resistant tuberculosis (MDR-TB).
Roughly 5.5 million patients worldwide have taken fluoxetine since the FDA approved it in 1987, according to manufacturer Eli Lilly and Co. in Indianapolis.
Eli Lilly and Co. and Locemia Solutions announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin.